These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38416311)

  • 1. Recent Advances in Clinical Trials in Multiple System Atrophy.
    Bendetowicz D; Fabbri M; Sirna F; Fernagut PO; Foubert-Samier A; Saulnier T; Le Traon AP; Proust-Lima C; Rascol O; Meissner WG
    Curr Neurol Neurosci Rep; 2024 Apr; 24(4):95-112. PubMed ID: 38416311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy.
    Koga S; Dickson DW
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):175-184. PubMed ID: 28860330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple system atrophy of the cerebellar type: clinical state of the art.
    Lin DJ; Hermann KL; Schmahmann JD
    Mov Disord; 2014 Mar; 29(3):294-304. PubMed ID: 24615754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards translational therapies for multiple system atrophy.
    Kuzdas-Wood D; Stefanova N; Jellinger KA; Seppi K; Schlossmacher MG; Poewe W; Wenning GK
    Prog Neurobiol; 2014 Jul; 118():19-35. PubMed ID: 24598411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple system atrophy.
    Poewe W; Stankovic I; Halliday G; Meissner WG; Wenning GK; Pellecchia MT; Seppi K; Palma JA; Kaufmann H
    Nat Rev Dis Primers; 2022 Aug; 8(1):56. PubMed ID: 36008429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.
    Jellinger KA
    J Alzheimers Dis; 2018; 62(3):1141-1179. PubMed ID: 28984582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second consensus statement on the diagnosis of multiple system atrophy.
    Gilman S; Wenning GK; Low PA; Brooks DJ; Mathias CJ; Trojanowski JQ; Wood NW; Colosimo C; Dürr A; Fowler CJ; Kaufmann H; Klockgether T; Lees A; Poewe W; Quinn N; Revesz T; Robertson D; Sandroni P; Seppi K; Vidailhet M
    Neurology; 2008 Aug; 71(9):670-6. PubMed ID: 18725592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple system atrophy.
    Fanciulli A; Stankovic I; Krismer F; Seppi K; Levin J; Wenning GK
    Int Rev Neurobiol; 2019; 149():137-192. PubMed ID: 31779811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy.
    Mészáros L; Riemenschneider MJ; Gassner H; Marxreiter F; von Hörsten S; Hoffmann A; Winkler J
    Acta Neuropathol Commun; 2021 Apr; 9(1):68. PubMed ID: 33853667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple System Atrophy - State of the Art.
    Laurens B; Vergnet S; Lopez MC; Foubert-Samier A; Tison F; Fernagut PO; Meissner WG
    Curr Neurol Neurosci Rep; 2017 May; 17(5):41. PubMed ID: 28378233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Multiple system atrophy: emerging targets for interventional therapies.
    Stefanova N; Wenning GK
    Neuropathol Appl Neurobiol; 2016 Feb; 42(1):20-32. PubMed ID: 26785838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple System Atrophy: Recent Developments and Future Perspectives.
    Meissner WG; Fernagut PO; Dehay B; Péran P; Traon AP; Foubert-Samier A; Lopez Cuina M; Bezard E; Tison F; Rascol O
    Mov Disord; 2019 Nov; 34(11):1629-1642. PubMed ID: 31692132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy.
    Mészáros L; Hoffmann A; Wihan J; Winkler J
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative cellular changes in multiple system atrophy brains.
    Andersen AM; Kaalund SS; Marner L; Salvesen L; Pakkenberg B; Olesen MV
    Neuropathol Appl Neurobiol; 2023 Dec; 49(6):e12941. PubMed ID: 37812040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current experimental disease-modifying therapeutics for multiple system atrophy.
    Lemos M; Wenning GK; Stefanova N
    J Neural Transm (Vienna); 2021 Oct; 128(10):1529-1543. PubMed ID: 34398313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases.
    Carmona-Abellan M; Del Pino R; Murueta-Goyena A; Acera M; Tijero B; Berganzo K; Gabilondo I; Gómez-Esteban JC
    Neurologia (Engl Ed); 2023; 38(9):609-616. PubMed ID: 37996211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.
    Prusiner SB; Woerman AL; Mordes DA; Watts JC; Rampersaud R; Berry DB; Patel S; Oehler A; Lowe JK; Kravitz SN; Geschwind DH; Glidden DV; Halliday GM; Middleton LT; Gentleman SM; Grinberg LT; Giles K
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5308-17. PubMed ID: 26324905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models of multiple system atrophy.
    Fellner L; Wenning GK; Stefanova N
    Curr Top Behav Neurosci; 2015; 22():369-93. PubMed ID: 24338664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy.
    Martinez-Valbuena I; Visanji NP; Kim A; Lau HHC; So RWL; Alshimemeri S; Gao A; Seidman MA; Luquin MR; Watts JC; Lang AE; Kovacs GG
    Transl Neurodegener; 2022 Feb; 11(1):7. PubMed ID: 35125105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuropathology, pathophysiology and genetics of multiple system atrophy.
    Ahmed Z; Asi YT; Sailer A; Lees AJ; Houlden H; Revesz T; Holton JL
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):4-24. PubMed ID: 22074330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.